InterCure Ltd. (INCR)
1.69
0.06 (3.68%)
At close: Jan 14, 2025, 2:17 PM
1.69
0.00%
After-hours Jan 14, 2025, 02:17 PM EST
undefined% (undefined)
| Bid | 1.59 |
| Market Cap | 77.34M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -4.57 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 1.71 |
| Volume | 25,276 |
| Avg. Volume (20D) | 42,498 |
| Open | 1.65 |
| Previous Close | 1.63 |
| Day's Range | 1.65 - 1.69 |
| 52-Week Range | 1.17 - 3.72 |
| Beta | undefined |
About INCR
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel....
Sector Healthcare
IPO Date Jan 28, 2019
Employees 270
Stock Exchange NASDAQ
Ticker Symbol INCR
Website https://www.intercure.co
Analyst Forecast
According to 1 analyst ratings, the average rating for INCR stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
3 weeks ago ·
Source
+11.19%
Intercure shares are trading higher after the comp...
Unlock content with
Pro Subscription
4 months ago ·
Source
+1.79%
Intercure shares are trading higher. The company reported H1 financial results.
